BUCK KRISTEN K (EVP, R&D and CMO) received a stock award from LISATA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 10/2/2024ACC: 0001879231-24-000004
Officer· EVP, R&D and CMO
Since Sep 2021
+8.64K
Net shares
Net buyer
$18.6K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
15K acquired · 6.36K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+15K
Price / share
$2.93
Trade value
$43.95K
% of position
27.8%
10/1/2024
54.03K→69.03K
Common Stock
Direct
Shares
−6.36K
Price / share
$2.93
Trade value
$18.64K
% of position
9.2%
10/1/2024
69.03K→62.67K
Total
Net shares
+8.64K
Net value
$25.31K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/1/2024 | A · Award | +15K | $2.93 | $43.95K | 27.8% | 54.03K | 69.03K |
| Common Stock Direct | 10/1/2024 | F · Tax Withholding | −6.36K | $2.93 | $18.64K | 9.2% | 69.03K | 62.67K |
| Total | +8.64K | $25.31K | ||||||
Derivative Transactions0
No derivative transactions reported